In our study, the MTT assay and EdU staining assay showed that HHLA2-overexpressing ovarian cancer cells exhibited decreased proliferation ability compared with the normal groups, indicating that HHLA2 can inhibit the proliferation of ovarian cancer cells independent of an immune environment. This evidence concerns the gene HHLA2 and ovarian carcinoma.